Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis—Coverage of TCT 2023
AGENT IDE is a prospective, randomized, multicenter, superiority trial comparing the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR.
Each week, we choose a study that we believe will be of interest to the interventional cardiology community and discuss it at a virtual Journal Club with several of our faculty members.
Panelists
Presenter
